Annovis Bio Announces Publication of Patents Covering the Treatment of Amyloid Lateral Sclerosis, Huntington’s Disease and Prion Diseases

By WebmasterSeptember 13, 2022November 1st, 2024No Comments

Annovis Bio Announces Publication of Patents Covering the Treatment of Amyloid Lateral Sclerosis, Huntington’s Disease and Prion Diseases

Previous PostRocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy
Next PostInnervace Secures Up to $40 Million to Advance Novel Regenerative Medicine Platform for Neurological Disorders